Presentations 2015

Several presentations were held during Uppsala Health Summit 2015, each centering on a different aspect of how to act on the growing threat of antibiotic resistance. Please find Videos from all plenary sessions here! 

Presentations in plenary

Plenary session: Framing the issue

• Dr. Gilles Forte, Global action plan to combat antimicrobial resistance
• Otto Cars, Professor, Uppsala University, Senior Advisor and Founder, ReAct
• Dr. Suwit Wibulpolprasert, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health
• John F. Ryan, Acting Director of the European Commission Public Health Directorate

Panel discussion: Gain political commitment and reach implementation

• Dr. Hetty Van Beers-Schreurs, Gain political commitment and reach implementation 
• Martha Gyansa-Lutterodt, B.Pharm, MA Health Policy, Director of Pharmaceutical Services, Ghana Ministry of Health
• Dr. Suwit Wibulpolprasert, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health

Plenary session: Actions needed​

• Dr. Manica Balasegaram, The GAP for AMR: from Action Plan to operations (PDF)
• Professor Ramanan Laxminarayan, Economic Benefits of Antibiotic Growth Promoters in Livestock
• Brendan Barnes, Director IP and Global Health, European Federation of Pharmaceutical Industries

Workshop Presentations

Workshop A: Access not Excess

• Dr Suwit Wibulpolprasert, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health, Access vs. Excess to Antimicrobial under the Universal Health Coverage Systems in Thailand

Workshop B: New economic models addressing antibiotic resistance

• Professor John-Arne Røttingen, Division Director, Norwegian Institute of Public Health; Adjunct Professor, Harvard School of Public Health, New Economic Models Addressing Antibiotic Resistance 
• Professor Kevin Outterson, Visiting Fellow, Centre for Global Health Security, Royal Institute for International Affairs; Professor, Boston University School of Law and Boston University School of Public Health New Business Models for Antibiotics 

Workshop C: The environmental dimension of antibiotic resistance

• Anja Leetz, Executive Director, Healthcare Without Harm, AMR & the environment 

Workshop D: Research and innovation for new therapies - collaborative models

• Professor Sarala Balachandran, Professor, Project Director, Open Source Drug Discovery (OSDD); Chief Scientist, Council of Scientific and Industrial Research (CSIR), Open Source Drug Discovery (OSDD) and other collaborative models 
• James Andersson, M.Sc., MBA, Head of Corporate Government Affairs, GSK, Collaborative Models for Antibacterial R&D 

Workshop E: Improved diagnostics for public health and surveillance

• Dr. Francis Moussy, PhD, Focal Point Diagnostics Innovation, Essential Medicines & Health Products, WHO, Multipurpose Open Point-of-Care Diagnostic Platforms for LMICs
• Dr. Catharina Boehme, Chief Executive Officer, FIND, Switzerland, Improved Diagnostics to fight AMR: Barriers to Development and Uptake (PDF)

Workshop F: Antibiotics in animal production

• Professor Henning Steinfield, Professor, Coordinator Livestock Information, Sector Analysis and Policy Branch (AGAL), Food and Agricultural Organization of the United Nations (FAO); Stanford University, The use of anti-microbials in animal production
• Professor Dick Heederik, Chair of the Expert Committee of the Netherlands Veterinary, Antimicrobial usage in the livestock sector: history, lessons learned and perspectives